5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide

C76H89N25O8S — CID 158847084

IUPAC5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide
SMILESC[C@@H]1[C@H](CC(=O)c2ccc(-c3ncco3)cc2)CCCN1c1cnc(C(N)=O)c(Nc2cnn(C)c2)n1.C[C@@H]1[C@H](CC(=O)c2noc(C(C)(C)C)n2)CCCN1c1cnc(C(N)=O)c(Nc2cnn(C)c2)n1.Cc1ncc(-c2ccc(C(=O)C[C@@H]3CCCN(c4cnc(C(N)=O)c(Nc5cnn(C)c5)n4)[C@@H]3C)cc2)s1
InChIInChI=1S/C27H30N8O2S.C26H28N8O3.C23H31N9O3/c1-16-20(11-22(36)18-6-8-19(9-7-18)23-13-29-17(2)38-23)5-4-10-35(16)24-14-30-25(26(28)37)27(33-24)32-21-12-31-34(3)15-21;1-16-19(12-21(35)17-5-7-18(8-6-17)26-28-9-11-37-26)4-3-10-34(16)22-14-29-23(24(27)36)25(32-22)31-20-13-30-33(2)15-20;1-13-14(9-16(33)20-29-22(35-30-20)23(2,3)4)7-6-8-32(13)17-11-25-18(19(24)34)21(28-17)27-15-10-26-31(5)12-15/h6-9,12-16,20H,4-5,10-11H2,1-3H3,(H2,28,37)(H,32,33);5-9,11,13-16,19H,3-4,10,12H2,1-2H3,(H2,27,36)(H,31,32);10-14H,6-9H2,1-5H3,(H2,24,34)(H,27,28)/t16-,20+;16-,19+;13-,14+/m111/s1
InChIKeyIYYWPBDERVKABZ-KYEWYFTNSA-N
MW1512.78 g/mol
LogP10.56
Rot. Bonds23

About 5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide

5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide (PubChem CID 158847084) has the molecular formula C76H89N25O8S and a molecular weight of 1512.78 g/mol. Its IUPAC name is 5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide.

Molecular Properties

Compound Name5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide
PubChem CID158847084
Molecular FormulaC76H89N25O8S
Molecular Weight1512.78 g/mol
Exact Mass1511.70
IUPAC Name5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide
SMILESC[C@@H]1[C@H](CC(=O)c2ccc(-c3ncco3)cc2)CCCN1c1cnc(C(N)=O)c(Nc2cnn(C)c2)n1.C[C@@H]1[C@H](CC(=O)c2noc(C(C)(C)C)n2)CCCN1c1cnc(C(N)=O)c(Nc2cnn(C)c2)n1.Cc1ncc(-c2ccc(C(=O)C[C@@H]3CCCN(c4cnc(C(N)=O)c(Nc5cnn(C)c5)n4)[C@@H]3C)cc2)s1
InChIInChI=1S/C27H30N8O2S.C26H28N8O3.C23H31N9O3/c1-16-20(11-22(36)18-6-8-19(9-7-18)23-13-29-17(2)38-23)5-4-10-35(16)24-14-30-25(26(28)37)27(33-24)32-21-12-31-34(3)15-21;1-16-19(12-21(35)17-5-7-18(8-6-17)26-28-9-11-37-26)4-3-10-34(16)22-14-29-23(24(27)36)25(32-22)31-20-13-30-33(2)15-20;1-13-14(9-16(33)20-29-22(35-30-20)23(2,3)4)7-6-8-32(13)17-11-25-18(19(24)34)21(28-17)27-15-10-26-31(5)12-15/h6-9,12-16,20H,4-5,10-11H2,1-3H3,(H2,28,37)(H,32,33);5-9,11,13-16,19H,3-4,10,12H2,1-2H3,(H2,27,36)(H,31,32);10-14H,6-9H2,1-5H3,(H2,24,34)(H,27,28)/t16-,20+;16-,19+;13-,14+/m111/s1
InChIKeyIYYWPBDERVKABZ-KYEWYFTNSA-N
XLogP10.56
TPSA434.93 Ų
H-Bond Donors6
H-Bond Acceptors31
Rotatable Bonds23
Heavy Atoms110
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001512.78
LogP ≤ 510.56
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1031

Analyze 5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide?
The IUPAC name of 5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide (CID 158847084) is 5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide.
What is the SMILES notation for 5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide?
The canonical SMILES for 5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide is C[C@@H]1[C@H](CC(=O)c2ccc(-c3ncco3)cc2)CCCN1c1cnc(C(N)=O)c(Nc2cnn(C)c2)n1.C[C@@H]1[C@H](CC(=O)c2noc(C(C)(C)C)n2)CCCN1c1cnc(C(N)=O)c(Nc2cnn(C)c2)n1.Cc1ncc(-c2ccc(C(=O)C[C@@H]3CCCN(c4cnc(C(N)=O)c(Nc5cnn(C)c5)n4)[C@@H]3C)cc2)s1.
What is the InChIKey of 5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide?
The InChIKey is IYYWPBDERVKABZ-KYEWYFTNSA-N. The full InChI is InChI=1S/C27H30N8O2S.C26H28N8O3.C23H31N9O3/c1-16-20(11-22(36)18-6-8-19(9-7-18)23-13-29-17(2)38-23)5-4-10-35(16)24-14-30-25(26(28)37)27(33-24)32-21-12-31-34(3)15-21;1-16-19(12-21(35)17-5-7-18(8-6-17)26-28-9-11-37-26)4-3-10-34(16)22-14-29-23(24(27)36)25(32-22)31-20-13-30-33(2)15-20;1-13-14(9-16(33)20-29-22(35-30-20)23(2,3)4)7-6-8-32(13)17-11-25-18(19(24)34)21(28-17)27-15-10-26-31(5)12-15/h6-9,12-16,20H,4-5,10-11H2,1-3H3,(H2,28,37)(H,32,33);5-9,11,13-16,19H,3-4,10,12H2,1-2H3,(H2,27,36)(H,31,32);10-14H,6-9H2,1-5H3,(H2,24,34)(H,27,28)/t16-,20+;16-,19+;13-,14+/m111/s1.
What are the key properties of 5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide?
5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide has a molecular weight of 1512.78 g/mol, XLogP of 10.56, 23 rotatable bonds, 6 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(2R,3S)-3-[2-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-2-oxoethyl]-2-methylpiperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(2-methyl-1,3-thiazol-5-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide;5-[(2R,3S)-2-methyl-3-[2-[4-(1,3-oxazol-2-yl)phenyl]-2-oxoethyl]piperidin-1-yl]-3-[(1-methylpyrazol-4-yl)amino]pyrazine-2-carboxamide is sourced from PubChem (CID 158847084), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).